Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer.
García M, Martinez-Villacampa M, Santos C, Navarro V, Teule A, Losa F, Pisa A, Cambray M, Soler G, Lema L, Kreisler E, Figueras A, Juan XS, Viñals F, Biondo S, Salazar R. García M, et al. Among authors: lema l. BMC Cancer. 2015 Feb 26;15:59. doi: 10.1186/s12885-015-1052-0. BMC Cancer. 2015. PMID: 25886275 Free PMC article. Clinical Trial.
Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients.
Montagut C, Iglesias M, Arumi M, Bellosillo B, Gallen M, Martinez-Fernandez A, Martinez-Aviles L, Cañadas I, Dalmases A, Moragon E, Lema L, Serrano S, Rovira A, Rojo F, Bellmunt J, Albanell J. Montagut C, et al. Among authors: lema l. Br J Cancer. 2010 Mar 30;102(7):1137-44. doi: 10.1038/sj.bjc.6605612. Epub 2010 Mar 16. Br J Cancer. 2010. PMID: 20234366 Free PMC article.
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2- advanced breast cancer: a real-world evidence cohort.
Sánchez-Bayona R, Lopez de Sa A, Jerez Gilarranz Y, Sanchez de Torre A, Alva M, Echavarria I, Moreno F, Tolosa P, Herrero Lopez B, de Luna A, Lema L, Gamez Casado S, Madariaga A, López-Tarruella S, Manso L, Bueno-Muiño C, Garcia-Saenz JA, Ciruelos E, Martin M. Sánchez-Bayona R, et al. Among authors: lema l. Breast Cancer Res Treat. 2024 Aug;206(3):551-559. doi: 10.1007/s10549-024-07324-8. Epub 2024 May 4. Breast Cancer Res Treat. 2024. PMID: 38703285
Proactive assessment of patient reported outcomes in ovarian cancer studies: a systematic review and call for action in future studies.
Madariaga A, Sánchez-Bayona R, Kasherman L, Estrada-Lorenzo JM, Manso L, Tolosa P, Alva M, Lema L, González-Deza C, Ciruelos E, Valcarcel D, Lheureux S, Oza AM. Madariaga A, et al. Among authors: lema l. Int J Gynecol Cancer. 2024 Oct 8:ijgc-2024-005883. doi: 10.1136/ijgc-2024-005883. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 39379328
ViSHWaS: Violence Study of Healthcare Workers and Systems-a global survey.
Banga A, Mautong H, Alamoudi R, Faisal UH, Bhatt G, Amal T, Mendiratta A, Bollu B, Kutikuppala LVS, Lee J, Simadibrata DM, Huespe I, Khalid A, Rais MA, Adhikari R, Lakhani A, Garg P, Pattnaik H, Gandhi R, Pandit R, Ahmad F, Camacho-Leon G, Ciza N P, Barrios N, Meza K, Okonkwo S, Dhabuliwo A, Hamza H, Nemat A, Essar MY, Kampa A, Qasba RK, Sharma P, Dutt T, Vekaria P, Bansal V, Nawaz FA, Surani S, Kashyap R; For GRRSP-ViSHWaS Study Group. Banga A, et al. BMJ Glob Health. 2023 Sep;8(9):e013101. doi: 10.1136/bmjgh-2023-013101. BMJ Glob Health. 2023. PMID: 37696546 Free PMC article.
50 results